REPLICEL LIFE SCIENCES
RepliCel’s current research activity is focused on the company’s core understanding of the unique biological function of hair follicle cells. Two distinct autologous cell therapies are currently in development. The first is a cellular treatment for androgenetic alopecia (pattern baldness) named RepliCel Hair-01 (RCH-01). The second is a cell therapy for the treatment of chronic tendon injuries named RepliCel Tendon-01 (RCT-01).
REPLICEL LIFE SCIENCES
Industry:
Biotechnology Clinical Trials Health Care Therapeutics
Founded:
2010-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.replicel.com
Total Employee:
1+
Status:
Active
Contact:
604-248-8730
Email Addresses:
[email protected]
Total Funding:
8.57 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
MainPointe Pharmaceuticals
MainPointe Pharmaceuticals investment in Post-IPO Equity - RepliCel Life Sciences
YOFOTO
YOFOTO investment in Post-IPO Equity - RepliCel Life Sciences
Official Site Inspections
http://www.replicel.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.52 K
- Host name: ec2-35-183-91-107.ca-central-1.compute.amazonaws.com
- IP address: 35.183.91.107
- Location: Montreal Canada
- Latitude: 45.4995
- Longitude: -73.5848
- Timezone: America/Toronto
- Postal: H3G
More informations about "RepliCel Life Sciences"
RepliCel
RepliCel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.See details»
For Investors - RepliCel
RepliCel Life Sciences is a biotechnology company headquartered in the rapidly emerging lifesciences hub in Vancouver, Canada specializing in the rapidly growing biotechnology …See details»
About Replicel
RepliCel Life Sciences Inc. - LinkedIn
RepliCel Life Sciences Inc. is leading a revolution in the development of products for sports medicine and aesthetics. We are a regenerative medicine company developing innovative, …See details»
RepliCel Life Sciences - Crunchbase Company Profile
RepliCel is a regenerative medicine company with a focus on aesthetics and orthopedics. Its cell therapy products are tailor-made to restore cellular function rejuvenate aging or sun-damaged skin, regrow hair, and repair tendons.See details»
RepliCel - Wikipedia
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. [1] The company focuses on development of cell therapies using a patient's own …See details»
RepliCel Provides Corporate Update - Yahoo Finance
Nov 28, 2022 · RepliCel Life Sciences Inc. (TSXV:RP) (OTC PINK:REPCF) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to provide the...See details»
RepliCel Applies for Manufacturing Approval for Its Collagen and …
Jul 7, 2021 · RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the Company believes is approximately …See details»
RepliCel's Phase 1 Clinical Trial for Hair Loss Succeeds in
Mar 14, 2017 · "As we march toward commercialization of this product based on this first-in-human data, our aim is to revolutionize the way we prevent, treat, and even reverse hair loss," …See details»
RepliCel Q3 2020 Management Update - GlobeNewswire
Sep 14, 2020 · As industry reestablishes global supply chains and business patterns from the lasting impact of pandemic slow-downs, I am pleased to provide this much-anticipated update …See details»
REPLICEL LIFE SCIENCES | VentureRadar
Website: http://replicel.com/ RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies …See details»
Investor FAQs - RepliCel
You can speak with someone from the company by calling 604-248-8730 or by emailing [email protected]. You can also go to the Contact section of our website. Can I be notified by …See details»
RepliCel Company Profile - Office Locations, Competitors, Revenue ...
See insights on RepliCel including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
RepliCel - Products, Competitors, Financials, Employees, …
RepliCel is a regenerative medicine company focused on developing autologous cell therapies for the healthcare sector. Use the CB Insights Platform to explore RepliCel's full profile.See details»
RepliCel Life Sciences Inc. | Vancouver BC - Facebook
RepliCel Life Sciences Inc., Vancouver, British Columbia. 9,505 likes · 2 talking about this · 9 were here. Using cells for healing.See details»
For Patients - RepliCel
Website by Centrifuge Media Lab. Information for patients regarding Replicel's hair, skin, and tendon studies for pattern baldness, aging and sun-damaged skin, and tendinosis.See details»
RepliCel - Company Presentation - YouTube
Presented by: David Hall, CEORepliCel is a regenerative medicine company focused on autologous cell therapies that address diseases caused by a deficit of he...See details»
RepliCel Closes $1 Million Final Tranche of Strategic Investment ...
Jan 4, 2022 · RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the Company believes is approximately …See details»
#rp RepliCel Life Sciences Inc. (RP.V) - CEO.CA
Sep 11, 2024 · Real-time discussion about RepliCel Life Sciences Inc. (RP.V) on CEO.CA, an investment chat community for Canada's small cap marketsSee details»
News - RepliCel
RepliCel Life Sciences Announces Arbitration Decision VANCOUVER, BC – October 16, 2023 - RepliCel Life... Press Release RepliCel Announces DermaPreciseâ„¢ Development Milestone, …See details»